QUESTRAN
CHOLESTYRAMINE
Approval overview QUESTRAN is listed in Drugs@FDA under application 016640 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient CHOLESTYRAMINE Form and strength POWDER;ORAL - EQ 4GM RESIN/SCOOPFUL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor BRISTOL MYERS Submission history Latest submission status date: 1997-08-22 00:00:00.
Structured Monograph
Clinical summary
Approval overview QUESTRAN is listed in Drugs@FDA under application 016640 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CHOLESTYRAMINE Form and strength POWDER;ORAL - EQ 4GM RESIN/SCOOPFUL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor BRISTOL MYERS Submission history Latest submission status date: 1997-08-22 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.